Financials
- Market Capitalization 764.14 M
- Employee 174
- Founded 1996
- CEO N/A
- Website www.rigel.com
- Headquarter Delaware, United States
- FIGI BBG000BPWTW7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2632 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 13.18 USD | -1.27% | -5.79% | +2.89% | +23.87% | 779.14 M USD | ||
| 2640 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.74 USD | -2.52% | -8.40% | -21.42% | -15.96% | 768.61 M USD | ||
| 2650 | CLYM Climb Bio, Inc. - Common Stock | 13.21 USD | -5.64% | +0.30% | +13.29% | +141.50% | 756.41 M USD | ||
| 2672 | OMER Omeros Corporation - Common Stock | 10.01 USD | -2.63% | -3.29% | +13.49% | +152.78% | 724.48 M USD |
Frequently asked questions about Rigel Pharmaceuticals, Inc. - Common Stock
What is the Rigel Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) is 41.3. Over the past 24 hours, the stock has changed by -2.94%. Follow the RIGL chart for real-time price dynamics.
What is the stock ticker of Rigel Pharmaceuticals, Inc. - Common Stock?
Rigel Pharmaceuticals, Inc. - Common Stock trades under the ticker RIGL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rigel Pharmaceuticals, Inc. - Common Stock stock going up?
RIGL has changed by +1.57% over the last week, +24.25% over the last month, and +37.07% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Rigel Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Rigel Pharmaceuticals, Inc. - Common Stock reported net income of 8.65 M for the last quarter. The previous quarter showed 268.06 M, which means net income changed by -96.77%.
How many employees does Rigel Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Rigel Pharmaceuticals, Inc. - Common Stock has 174 employees. Workforce size can provide additional context about the company's scale and operations.
What is Rigel Pharmaceuticals, Inc. - Common Stock EBITDA?
Rigel Pharmaceuticals, Inc. - Common Stock EBITDA is 12.48 M, and its EBITDA margin is 21.22%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Rigel Pharmaceuticals, Inc. - Common Stock stock?
You can buy Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rigel Pharmaceuticals, Inc. - Common Stock stock?
Investing in Rigel Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RIGL chart and related analysis on metatrader.com as part of your research.